Hoffman Robert is President, CEO and Interim CFO of Kintara Therapeutics Inc.
Person profile
Roles
Kintara Therapeutics
President, CEO and Interim CFO
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
3
FibroBiologics, Inc.
7 Feb 24
4
Kintara Therapeutics, Inc.
1 Sep 23
4
Kintara Therapeutics, Inc.
2 Jun 23
4
Kintara Therapeutics, Inc.
3 Aug 22
4
Kintara Therapeutics, Inc.
17 Feb 22
4
Kintara Therapeutics, Inc.
10 Nov 21
4
Kintara Therapeutics, Inc.
22 Sep 21
4
Kura Oncology, Inc.
23 Jun 21
4
Kintara Therapeutics, Inc.
17 Sep 20
4
DelMar Pharmaceuticals, Inc.
30 Jun 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Aug 23 | KTRA Kintara Therapeutics | Options Common Stock | Grant | Acquire A | No | No | 4.655 | 23,142 | 107.73 k | 23,142 |
1 Jun 23 | KTRA Kintara Therapeutics | Common Stock, par value $0.001 per share | Grant | Acquire A | No | No | 0 | 59,800 | 0.00 | 68,902 |